PEOPLE - Changes at Arrow International:
This article was originally published in Clinica
Executive Summary
Reading, Pennsylvania-based Arrow International, a manufacturer of catheters for cardiac care, has made several management changes. Frederick Hirt has been promoted to senior vice-president of finance and CFO. He will also continue his role as a member of the management executive committee. Fellow member Carl Staples, head of human resources, has been appointed senior vice-president of HR. Philip Croxford has been promoted to group vice-president of critical care and cardiac assist and will become a member of the committee. James Hatlan has been promoted to senior vice-president of manufacturing and also becomes a member of the committee. The firm also announced the retirement of Philip Fleck, Arrow's president and COO, effective December 31 2004.
You may also be interested in...
California Court’s Inaction On TiO2 Prop 65 First Amendment Case Breeds New Lawsuits
The Personal Care Products Council seeks to stem the rising tide of titanium dioxide Proposition 65 lawsuits, requesting that a California court prohibit the state’s Attorney General and private enforcers from filing and/or prosecuting new suits against cosmetics companies failing to warn about potential TiO2 exposure.
Kenvue Breaks Ground On New Headquarters, Appoints Chief Corporate Affairs Officer
Firm hosts groundbreaking for 290,000 square-foot global headquarters it’s having built in Summit, NJ, starting with 100,000 square-foot science and innovation and expected to open in 2025. It announced adding Russell Dyer as chief corporate affairs officer starting 13 March.
Xaira Launches With $1bn-Plus And End-To-End AI Strategy
ARCH and Foresite incubated the company and recruited Genentech R&D veteran Marc Tessier-Lavigne to keep data generation, machine learning research and drug development under one roof.